COFACE SA (EPA:COFA): Set To Experience A Decrease In Earnings?

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card!

Since COFACE SA (EPA:COFA) released its earnings in September 2018, analyst consensus outlook seem bearish, with profits predicted to drop by -8.0% next year. Though this is still an improvement on its past 5-year earnings growth rate of -11%, on average. Presently, with latest-twelve-month earnings at €83m, we should see this fall to €77m by 2020. In this article, I've outline a few earnings growth rates to give you a sense of the market sentiment for COFACE in the longer term. For those keen to understand more about other aspects of the company, you can research its fundamentals here.

Check out our latest analysis for COFACE

Advertisement

How will COFACE perform in the near future?

The longer term view from the 6 analysts covering COFA is one of positive sentiment. Since forecasting becomes more difficult further into the future, broker analysts generally project out to around three years. To get an idea of the overall earnings growth trend for COFA, I’ve plotted out each year’s earnings expectations and inserted a line of best fit to determine an annual rate of growth from the slope of this line.

ENXTPA:COFA Future Profit February 13th 19
ENXTPA:COFA Future Profit February 13th 19

From the current net income level of €83m and the final forecast of €81m by 2022, the annual rate of growth for COFA’s earnings is 1.5%. This leads to an EPS of €0.84 in the final year of projections relative to the current EPS of €0.53. Analysts are predicting this high revenue growth to squeeze profit margins over time, from 5.9% to 5.4% by the end of 2022.

Next Steps:

Future outlook is only one aspect when you're building an investment case for a stock. For COFACE, there are three key factors you should look at:

  1. Financial Health: Does it have a healthy balance sheet? Take a look at our free balance sheet analysis with six simple checks on key factors like leverage and risk.
  2. Valuation: What is COFACE worth today? Is the stock undervalued, even when its growth outlook is factored into its intrinsic value? The intrinsic value infographic in our free research report helps visualize whether COFACE is currently mispriced by the market.
  3. Other High-Growth Alternatives : Are there other high-growth stocks you could be holding instead of COFACE? Explore our interactive list of stocks with large growth potential to get an idea of what else is out there you may be missing!

To help readers see past the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price-sensitive company announcements.

The author is an independent contributor and at the time of publication had no position in the stocks mentioned. For errors that warrant correction please contact the editor at editorial-team@simplywallst.com.

Simply Wall St analyst Simply Wall St and Simply Wall St have no position in any of the companies mentioned. This article is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

About ENXTPA:COFA

COFACE

Through its subsidiaries, provides trade credit insurance products and services for small and medium enterprises, mid-market companies, international corporations, international companies, financial institutions, and clients of distribution partners.

Good value average dividend payer.

Advertisement

Weekly Picks

CE
Ceazar
CNXU logo
Ceazar on Conexeu Sciences ·

This small biotech is developing technology that could potentially change how tissue is rebuilt

Fair Value:US$25.3458.4% undervalued
53 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
IN
Investingwilly
MA logo
Investingwilly on Mastercard ·

Mastercard: The Best Dividend Stock You're Ignoring

Fair Value:US$75034.9% undervalued
9 users have followed this narrative
0 users have commented on this narrative
3 users have liked this narrative
TR
tripledub
INTU logo
tripledub on Intuit ·

A Wonderful Business at a Not-So-Wonderful Price

Fair Value:US$56053.9% undervalued
44 users have followed this narrative
1 users have commented on this narrative
26 users have liked this narrative
TA
Talos
HYFT logo
Talos on MindWalk Holdings ·

The Asymmetric TechBio Play: MindWalk Holdings and the Valuation Disconnect

Fair Value:US$8.2782.0% undervalued
11 users have followed this narrative
0 users have commented on this narrative
4 users have liked this narrative

Updated Narratives

HA
HarishPK
DOX logo
HarishPK on Amdocs ·

Why Amdocs is a high conviction Buy for me?

Fair Value:US$82.0336.2% undervalued
2 users have followed this narrative
1 users have commented on this narrative
0 users have liked this narrative
DE
Delphic
SMR logo
Delphic on NuScale Power ·

NuScale is Postioned For Long-Term Growth

Fair Value:US$10089.1% undervalued
10 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
TR
WMT logo
Treasury_Raccoon_w0gg on Walmart ·

Walmart's 'Other' Segment Will Power New Growth Beyond Retail

Fair Value:US$154.5822.7% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

MA
martinarauz
NU logo
martinarauz on Nu Holdings ·

Investment Analysis (May 2026)

Fair Value:US$22.7444.6% undervalued
67 users have followed this narrative
0 users have commented on this narrative
16 users have liked this narrative
HA
HarishPK
ADBE logo
HarishPK on Adobe ·

Adobe: A Probabilistic Case for Undervaluation

Fair Value:US$319.9638.3% undervalued
61 users have followed this narrative
9 users have commented on this narrative
18 users have liked this narrative
HE
HedgeY
ASTS logo
HedgeY on AST SpaceMobile ·

AST SpaceMobile: The Boldest Direct-to-Cell Bet in Public Markets

Fair Value:US$17057.1% undervalued
51 users have followed this narrative
0 users have commented on this narrative
13 users have liked this narrative